应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LQDA Liquidia Technologies Inc
交易中 07-10 14:02:21 EDT
78.29
-3.16
-3.89%
最高
80.83
最低
76.15
成交量
67.57万
今开
80.59
昨收
81.45
日振幅
5.74%
总市值
69.59亿
流通市值
55.08亿
总股本
8,889万
成交额
5,256万
换手率
0.96%
流通股本
7,036万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|Liquidia盘中下跌5.66%,投行下调评级叠加董事密集减持承压
行情直击 · 07-10 22:21
异动解读|Liquidia盘中下跌5.66%,投行下调评级叠加董事密集减持承压
异动解读|Liquidia Technologies盘中上涨5.07%,评级下调超跌后反弹逼近目标价
行情直击 · 07-01
异动解读|Liquidia Technologies盘中上涨5.07%,评级下调超跌后反弹逼近目标价
异动解读|Liquidia Technologies盘中下跌5.37%,美银证券下调评级至中性
行情直击 · 06-29
异动解读|Liquidia Technologies盘中下跌5.37%,美银证券下调评级至中性
异动解读|Liquidia Technologies盘前上涨5.96%,YUTREPIA商业化势头强劲叠加学术会议催化
行情直击 · 06-29
异动解读|Liquidia Technologies盘前上涨5.96%,YUTREPIA商业化势头强劲叠加学术会议催化
异动解读|Liquidia Technologies夜盘上涨6.32%,报83.11美元
行情直击 · 06-29
异动解读|Liquidia Technologies夜盘上涨6.32%,报83.11美元
异动解读|Liquidia Technologies盘中上涨5.18%,报74.73美元
行情直击 · 06-23
异动解读|Liquidia Technologies盘中上涨5.18%,报74.73美元
异动解读|Liquidia盘中上涨7.26%,公司宣布在PHA国际肺动脉高压会议上展示研究海报
行情直击 · 06-11
异动解读|Liquidia盘中上涨7.26%,公司宣布在PHA国际肺动脉高压会议上展示研究海报
异动解读|Liquidia盘后上涨5.9%,报63.4美元
行情直击 · 06-06
异动解读|Liquidia盘后上涨5.9%,报63.4美元
异动解读|Liquidia盘中上涨15.51%,报64.325美元
行情直击 · 06-04
异动解读|Liquidia盘中上涨15.51%,报64.325美元
异动解读 | 多家投行上调目标价,Liquidia Technologies盘中大涨7.05%
异动解读 · 05-13
异动解读 | 多家投行上调目标价,Liquidia Technologies盘中大涨7.05%
异动解读 | Liquidia Technologies Inc盘中大涨5.37%,因第一季度扭亏为盈且营收超预期
异动解读 · 05-11
异动解读 | Liquidia Technologies Inc盘中大涨5.37%,因第一季度扭亏为盈且营收超预期
异动解读 | Liquidia盘前大涨8.04%,因第一季度扭亏为盈且营收超预期
异动解读 · 05-11
异动解读 | Liquidia盘前大涨8.04%,因第一季度扭亏为盈且营收超预期
Liquidia Corporation盘中异动 股价大涨5.13%
市场透视 · 03-06
Liquidia Corporation盘中异动 股价大涨5.13%
Liquidia Corporation盘中异动 快速跳水5.09%报31.88美元
市场透视 · 02-24
Liquidia Corporation盘中异动 快速跳水5.09%报31.88美元
Liquidia Corporation盘中异动 下午盘大幅上涨5.06%报44.03美元
市场透视 · 01-30
Liquidia Corporation盘中异动 下午盘大幅上涨5.06%报44.03美元
异动解读 | 杰富瑞上调目标价,Liquidia Technologies Inc盘中大涨5.01%
异动解读 · 01-14
异动解读 | 杰富瑞上调目标价,Liquidia Technologies Inc盘中大涨5.01%
Liquidia Corporation盘中异动 早盘股价大跌5.26%报14.04美元
市场透视 · 2025-03-10
Liquidia Corporation盘中异动 早盘股价大跌5.26%报14.04美元
Liquidia Corporation盘中异动 临近收盘大幅下跌5.10%报14.70美元
市场透视 · 2025-03-04
Liquidia Corporation盘中异动 临近收盘大幅下跌5.10%报14.70美元
Liquidia Corporation盘中异动 股价大跌6.65%
市场透视 · 2025-02-28
Liquidia Corporation盘中异动 股价大跌6.65%
Liquidia Corporation盘中异动 下午盘快速上涨5.02%报15.05美元
市场透视 · 2025-02-05
Liquidia Corporation盘中异动 下午盘快速上涨5.02%报15.05美元
加载更多
公司概况
公司名称:
Liquidia Technologies Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造,PRINT技术是一种粒子工程平台,能够精确生产均匀的药物颗粒,旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究,该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验,包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。
发行价格:
--
{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":78.285,"timestamp":1783706540158,"preClose":81.45,"halted":0,"volume":675659,"delay":0,"changeRate":-0.03885819521178645,"floatShares":70364536,"shares":88893621,"eps":0.244125,"marketStatus":"交易中","change":-3.165,"latestTime":"07-10 14:02:21 EDT","open":80.59,"high":80.825,"low":76.15,"amount":52560916.278083995,"amplitude":0.057397,"askPrice":78.34,"askSize":20,"bidPrice":78.18,"bidSize":156,"shortable":3,"etf":0,"ttmEps":0.244125,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1783713600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":81.45,"preHourTrading":{"tag":"盘前","latestPrice":80.8,"preClose":81.45,"latestTime":"09:29 EDT","volume":414,"amount":33672.53682,"timestamp":1783690199999,"change":-0.65,"changeRate":-0.00798,"amplitude":0.018785},"postHourTrading":{"tag":"盘后","latestPrice":82.14,"preClose":81.45,"latestTime":"19:24 EDT","volume":11899,"amount":969506.5197,"timestamp":1783639460478,"change":0.69,"changeRate":0.008471,"amplitude":0.012277},"volumeRatio":0.697221,"impliedVol":1.0193,"impliedVolPercentile":0.1992},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"1170534184","title":"异动解读|Liquidia盘中下跌5.66%,投行下调评级叠加董事密集减持承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1170534184","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170534184?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:21","pubTimestamp":1783693317,"startTime":"0","endTime":"0","summary":"7月10日,Liquidia盘中下跌5.66%,报76.84美元/股,成交额2070.57万美元。消息面上,美银证券此前将Liquidia评级从\"买入\"下调至\"中性\",目标价79美元。与此同时,公司董事Bloch Stephen M近期持续大规模减持,仅6月至7月初累计卖出超30万股,套现金额超2200万美元,频繁的内部人减持进一步加剧市场抛压。当前股价已跌破美银目标价,显示市场情绪偏弱。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117263612","title":"异动解读|Liquidia Technologies盘中上涨5.07%,评级下调超跌后反弹逼近目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1117263612","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117263612?lang=zh_cn&edition=full","pubTime":"2026-07-01 00:21","pubTimestamp":1782836516,"startTime":"0","endTime":"0","summary":"6月30日,Liquidia Technologies盘中上涨5.07%,报78.93美元/股,成交额3370.43万美元。消息面上,此前一交易日美银证券将公司评级从\"买入\"下调至\"中性\",目标价设定为79美元,引发获利回吐导致股价一度跌逾5%至73美元附近。当前股价反弹至接近目标价水平,显示市场消化评级调整后的估值修复。基本面方面,公司一季度EPS 0.52美元,超预期的0.41美元,核心产品YUTREPIA净产品销售额约1.3亿美元,同比扭亏为盈,独立患者处方超4500份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138967241","title":"异动解读|Liquidia Technologies盘中下跌5.37%,美银证券下调评级至中性","url":"https://stock-news.laohu8.com/highlight/detail?id=1138967241","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138967241?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:09","pubTimestamp":1782742182,"startTime":"0","endTime":"0","summary":"6月29日,Liquidia Technologies盘中下跌5.37%,报73.01美元/股,成交额3070.31万美元。消息面上,美银证券将Liquidia评级从\"买入\"下调至\"中性\",目标价设定为79美元。此前该股因YUTREPIA商业化放量及学术会议催化一度在盘前走高,但评级下调引发获利回吐压力。一季度公司实现EPS 0.52美元,超市场预期的0.41美元,净产品销售额约1.3亿美元,同比扭亏为盈。尽管基本面强劲,投行下调评级或暗示当前估值已充分反映利好,短期上行空间受限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128215928","title":"异动解读|Liquidia Technologies盘前上涨5.96%,YUTREPIA商业化势头强劲叠加学术会议催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1128215928","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128215928?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:02","pubTimestamp":1782720161,"startTime":"0","endTime":"0","summary":"6月29日,Liquidia Technologies盘前上涨5.96%,报80.97美元/股,成交额5.01万美元。消息面上,公司核心产品YUTREPIA商业化持续放量,一季度净产品销售额约1.3亿美元,超4500份独立患者处方,同比实现扭亏为盈(EPS 0.52美元,远超市场预期的0.41美元)。此外,公司于6月11日宣布将在PHA 2026国际肺动脉高压大会上发布海报数据,学术会议催化叠加业绩高增长预期,持续推升市场情绪。一季度业绩公布后,多家分析师上调目标价。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138192096","title":"异动解读|Liquidia Technologies夜盘上涨6.32%,报83.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138192096","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138192096?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:21","pubTimestamp":1782714114,"startTime":"0","endTime":"0","summary":"6月29日,Liquidia Technologies夜盘上涨6.32%,报83.11美元/股,成交额11.53万美元。Liquidia Technologies所在的制药行业中,个股中,礼来涨1.65%,强生跌0.18%,默沙东跌0.05%,Axsome Therapeutics涨0%,辉瑞涨0%。Liquidia Corporation是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前重点为肺动脉高压治疗。公司核心产品YUTREPIA已实现商业化,最新季度净产品销售额约1.3亿美元,患者处方数持续增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134348790","title":"异动解读|Liquidia Technologies盘中上涨5.18%,报74.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134348790","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134348790?lang=zh_cn&edition=full","pubTime":"2026-06-23 00:49","pubTimestamp":1782146976,"startTime":"0","endTime":"0","summary":"6月23日,Liquidia Technologies盘中上涨5.18%,报74.73美元/股,成交额7319.12万美元,股价突破此前52周高点73.22美元,创历史新高。Liquidia Technologies所在的制药行业中,个股表现分化,其中Definium Therapeutics涨50.84%,诺和诺德涨7.38%,礼来涨1.29%,强生涨1.21%,辉瑞跌0.42%。Liquidia Corporation是一家生物制药公司,专注于肺动脉高压治疗领域,通过专有的PRINT粒子工程技术平台进行新产品的研发与商业化,该技术能够精确生产均匀的药物颗粒,应用于吸入疗法、疫苗、生物制剂等多种给药途径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177797738","title":"异动解读|Liquidia盘中上涨7.26%,公司宣布在PHA国际肺动脉高压会议上展示研究海报","url":"https://stock-news.laohu8.com/highlight/detail?id=1177797738","media":"行情直击","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177797738?lang=zh_cn&edition=full","pubTime":"2026-06-11 22:55","pubTimestamp":1781189706,"startTime":"0","endTime":"0","summary":"消息面上,Liquidia当日宣布将在PHA国际肺动脉高压会议暨科学大会上展示研究海报,显示公司在核心治疗领域的研发进展持续推进。该消息叠加近期股价强势表现——此前一周内公司股价已累计大幅上涨,市场对其肺动脉高压管线的关注度持续升温。Liquidia所在的制药行业当日整体表现积极,辉瑞涨2.79%,礼来涨2.28%,默沙东涨1.53%,强生涨1.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184932935","title":"异动解读|Liquidia盘后上涨5.9%,报63.4美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184932935","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184932935?lang=zh_cn&edition=full","pubTime":"2026-06-06 05:17","pubTimestamp":1780694237,"startTime":"0","endTime":"0","summary":"6月6日,Liquidia盘后上涨5.9%,报63.4美元/股,成交额213.32万美元。Liquidia所在的制药行业中,个股中,礼来跌0.93%,强生跌0.33%,默沙东跌0.4%,辉瑞跌0.23%,施贵宝跌0.12%。Liquidia Corporation是一家生物制药公司,专注于肺动脉高压治疗领域,通过专有的PRINT粒子工程技术平台进行药物研发与商业化,该技术能精确生产均匀药物颗粒,应用于吸入疗法、疫苗、生物制剂等多种给药途径。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199387310","title":"异动解读|Liquidia盘中上涨15.51%,报64.325美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199387310","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199387310?lang=zh_cn&edition=full","pubTime":"2026-06-04 23:12","pubTimestamp":1780585979,"startTime":"0","endTime":"0","summary":"6月4日,Liquidia盘中上涨15.51%,报64.325美元/股,成交额1.12亿美元。Liquidia所在的制药行业中,个股中,礼来涨5.2%,强生涨1.51%,诺和诺德涨5.17%,默沙东涨3.06%,辉瑞涨1.42%。Liquidia Corporation是一家生物制药公司,专注于肺动脉高压治疗领域,通过专有的PRINT粒子工程技术平台进行药物研发与商业化,该技术能精确生产均匀药物颗粒,应用于吸入疗法、疫苗、生物制剂等多种给药途径。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178479646","title":"异动解读 | 多家投行上调目标价,Liquidia Technologies盘中大涨7.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178479646","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178479646?lang=zh_cn&edition=full","pubTime":"2026-05-13 03:59","pubTimestamp":1778615970,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc今日盘中股价大幅上涨7.05%,引起了投资者的广泛关注。消息面上,多家华尔街知名投行在周二发布的研究报告中上调了该公司的目标股价。分析师们普遍对Liquidia Technologies的未来前景表示乐观,这些积极的研究行动增强了市场信心,推动了股价上涨。分析师上调目标价通常基于对公司基本面、增长潜力或行业前景的积极评估。此次多家机构同时上调目标价,向市场传递了强烈的看涨信号,是推动该股在交易时段内表现强劲的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123650139","title":"异动解读 | Liquidia Technologies Inc盘中大涨5.37%,因第一季度扭亏为盈且营收超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123650139","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123650139?lang=zh_cn&edition=full","pubTime":"2026-05-11 22:20","pubTimestamp":1778509238,"startTime":"0","endTime":"0","summary":"生物制药公司Liquidia Technologies Inc(股票代码:LQDA)今日盘中大涨5.37%,引起了市场的广泛关注。消息面上,公司发布了强劲的第一季度财务业绩,成功实现扭亏为盈。报告显示,公司第一季度实现每股净利润52美分,而去年同期为每股净亏损45美分。同时,公司第一季度营收达到1.329亿美元,超过了市场预期的1.1668亿美元。业绩增长主要得益于其高血压药物Yutrepia的出色表现,该产品在第一季度实现了1.299亿美元的销售额,而去年同期该产品尚无销售额记录。此外,公司的现金及现金等价物总额也有所增加,财务状况稳健。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109193037","title":"异动解读 | Liquidia盘前大涨8.04%,因第一季度扭亏为盈且营收超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1109193037","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109193037?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:50","pubTimestamp":1778500249,"startTime":"0","endTime":"0","summary":"生物制药公司Liquidia Technologies Inc(股票代码:LQDA)今日盘前股价大幅上涨8.04%,引起了市场的广泛关注。消息面上,公司发布了强劲的第一季度财务业绩,成功实现扭亏为盈。报告显示,公司第一季度实现每股净利润52美分,而去年同期为每股净亏损45美分。同时,公司第一季度营收达到1.329亿美元,超过了市场预期的1.1668亿美元。业绩增长主要得益于其高血压药物Yutrepia的出色表现,该产品在第一季度实现了1.299亿美元的销售额,而去年同期该产品尚无销售额记录。此外,公司的现金及现金等价物总额也有所增加,财务状况稳健。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617574116","title":"Liquidia Corporation盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617574116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617574116?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:43","pubTimestamp":1772808196,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日22时43分,Liquidia Corporation股票出现波动,股价急速拉升5.13%。Liquidia Corporation股票所在的制药行业中,整体跌幅为1.14%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030622431697a8a13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030622431697a8a13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064131342.USD","LU0417517546.SGD","LU0256863811.USD","LU0320765489.SGD","BK4007","LU0256863902.USD","BK4161","LU0070302665.USD","LU0208291251.USD","PH","LU1988902786.USD","BK4585","LQDA","BK4580","LU1989772923.USD","LU2264538146.SGD","BK4588","LU0211331839.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613797386","title":"Liquidia Corporation盘中异动 快速跳水5.09%报31.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613797386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613797386?lang=zh_cn&edition=full","pubTime":"2026-02-24 01:27","pubTimestamp":1771867671,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日01时27分,Liquidia Corporation股票出现波动,股价快速下跌5.09%。截至发稿,该股报31.88美元/股,成交量86.4723万股,换手率0.99%,振幅6.58%。Liquidia Corporation股票所在的生物技术行业中,整体涨幅为0.07%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224012751a4bfa81a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224012751a4bfa81a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0208291251.USD","PH","LU0256863902.USD","BK4588","LU2264538146.SGD","LU0211331839.USD","LU1989772923.USD","BK4007","LU0417517546.SGD","BK4580","LU0256863811.USD","LU1989772840.SGD","BK4161","LU0070302665.USD","LU1988902786.USD","BK4585","LU0320765489.SGD","LU1064131342.USD","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607919053","title":"Liquidia Corporation盘中异动 下午盘大幅上涨5.06%报44.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607919053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607919053?lang=zh_cn&edition=full","pubTime":"2026-01-30 03:26","pubTimestamp":1769714791,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日03时26分,Liquidia Corporation股票出现波动,股价大幅拉升5.06%。截至发稿,该股报44.03美元/股,成交量242.493万股,换手率2.79%,振幅6.28%。Liquidia Corporation股票所在的生物技术行业中,整体跌幅为0.21%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130032631953efc5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130032631953efc5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417517546.SGD","LU1989772923.USD","PH","LU1064131342.USD","LU0320765489.SGD","LU0070302665.USD","LU2264538146.SGD","LU1988902786.USD","LU1989772840.SGD","BK4580","BK4007","BK4161","LQDA","LU0256863811.USD","BK4585","BK4588","LU0208291251.USD","LU0256863902.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172576951","title":"异动解读 | 杰富瑞上调目标价,Liquidia Technologies Inc盘中大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1172576951","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172576951?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:00","pubTimestamp":1768402836,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc(LQDA)今日盘中大涨5.01%,引起了市场的广泛关注。消息面上,杰富瑞(Jefferies)将Liquidia Corp的目标价从45美元上调至55美元,显示出分析师对该公司的乐观预期。这一调整可能是推动股价上涨的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518271351","title":"Liquidia Corporation盘中异动 早盘股价大跌5.26%报14.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518271351?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615313,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分,Liquidia Corporation股票出现异动,股价急速跳水5.26%。截至发稿,该股报14.04美元/股,成交量11.5394万股,换手率0.14%,振幅3.24%。Liquidia Corporation股票所在的生物技术行业中,整体涨幅为0.12%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220153a26a304e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220153a26a304e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417517546.SGD","BK4007","LQDA","BK4161","BK4588","LU0070302665.USD","LU0320765489.SGD","LU1989772840.SGD","LU0208291251.USD","LU0211331839.USD","LU0256863811.USD","LU1989772923.USD","BK4585","PH","BK4580","LU0256863902.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516623665","title":"Liquidia Corporation盘中异动 临近收盘大幅下跌5.10%报14.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516623665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516623665?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:35","pubTimestamp":1741034103,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时35分,Liquidia Corporation股票出现波动,股价大幅跳水5.10%。截至发稿,该股报14.70美元/股,成交量86.6047万股,换手率1.02%,振幅5.68%。Liquidia Corporation股票所在的生物技术行业中,整体跌幅为0.10%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043503989a6048&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043503989a6048&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863902.USD","BK4588","LU1989772840.SGD","LU0070302665.USD","PH","BK4585","LU0208291251.USD","LU1989772923.USD","BK4580","LU0320765489.SGD","LU0256863811.USD","LU0211331839.USD","BK4007","LQDA","BK4161","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514335664","title":"Liquidia Corporation盘中异动 股价大跌6.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514335664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514335664?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:54","pubTimestamp":1740678851,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时54分,Liquidia Corporation股票出现波动,股价快速下挫6.65%。Liquidia Corporation股票所在的生物技术行业中,整体涨幅为0.35%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228015411a256a925&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228015411a256a925&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1989772840.SGD","BK4588","LU0320765489.SGD","LU1989772923.USD","LU0417517546.SGD","LU0211331839.USD","BK4580","LQDA","LU0070302665.USD","LU0256863811.USD","PH","LU0208291251.USD","BK4007","LU0256863902.USD","BK4585","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509495082","title":"Liquidia Corporation盘中异动 下午盘快速上涨5.02%报15.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509495082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509495082?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:45","pubTimestamp":1738698311,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时45分,Liquidia Corporation股票出现异动,股价大幅拉升5.02%。截至发稿,该股报15.05美元/股,成交量38.3853万股,换手率0.45%,振幅4.99%。Liquidia Corporation股票所在的生物技术行业中,整体涨幅为1.63%。Liquidia Corporation公司简介:Liquidia Corp 是一家总部位于美国的生物制药公司,专注于开发、制造和商业化产品,以满足未满足的患者需求,目前的重点是肺动脉高压 和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050345119618082b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050345119618082b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PH","LU0070302665.USD","LU0211331839.USD","BK4161","LQDA","BK4007","LU0208291251.USD","LU0417517546.SGD","LU1989772840.SGD","BK4580","LU0320765489.SGD","LU0256863902.USD","BK4585","LU0256863811.USD","BK4588","LU1989772923.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":0.0319},{"period":"1month","weight":0.2725},{"period":"3month","weight":1.1128},{"period":"6month","weight":1.2713},{"period":"1year","weight":5.0423},{"period":"ytd","weight":1.3616}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司,专注于解决未满足患者需求产品的开发、制造和商业化,目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造,PRINT技术是一种粒子工程平台,能够精确生产均匀的药物颗粒,旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究,该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验,包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.042796},{"month":3,"riseRate":0.5,"avgChangeRate":-0.012167},{"month":4,"riseRate":0.375,"avgChangeRate":-0.058158},{"month":5,"riseRate":0.875,"avgChangeRate":0.19539},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029487},{"month":7,"riseRate":0.375,"avgChangeRate":-0.000138},{"month":8,"riseRate":0.5,"avgChangeRate":0.048271},{"month":9,"riseRate":0.375,"avgChangeRate":0.049793},{"month":10,"riseRate":0.625,"avgChangeRate":0.025896},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}